Phase 2 Myotonic Dystrophy 1 Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Myotonic Dystrophy 1
PepGen Inc24 enrolled8 locationsNCT06667453
Recruiting
Phase 2
An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)
Myotonic Dystrophy 1
PepGen Inc48 enrolled3 locationsNCT07220603
Recruiting
Phase 1Phase 2
Study of ATX-01 in Participants With DM1
Myotonic Dystrophy 1
ARTHEx Biotech S.L.56 enrolled12 locationsNCT06300307
Recruiting
Phase 1Phase 2
Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy
Myotonic Dystrophy 1
Arrowhead Pharmaceuticals78 enrolled11 locationsNCT06138743